Diclofenac Enables Unprecedented Week-Long Microneedle-Enhanced Delivery of a Skin Impermeable Medication in Humans
- 13 June 2013
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 30 (8) , 1947-1955
Abstract
Purpose Microneedles applied to the skin create micropores, allowing transdermal drug delivery of skin-impermeable compounds. The first human study with this technique demonstrated delivery of naltrexone (an opioid antagonist) for two to three days. Rapid micropore closure, however, blunts the delivery window. Application of diclofenac (an anti-inflammatory) allows seven days of naltrexone delivery in animals. The purpose of the current work was to demonstrate delivery of naltrexone for seven days following one microneedle treatment in humans. Methods Human subjects were treated with microneedles, diclofenac (or placebo), and naltrexone. Impedance measurements were used as a surrogate marker to measure micropore formation, and plasma naltrexone concentrations were measured for seven days post-microneedle application. Results Impedance dropped significantly from baseline to post-microneedle treatment, confirming micropore formation. Naltrexone was detected for seven days in Group 1 (diclofenac + naltrexone, n = 6), vs. 72 h in Group 2 (placebo + naltrexone, n = 2). At study completion, a significant difference in impedance was observed between intact and microneedle-treated skin in Group 1 (confirming the presence of micropores). Conclusion This is the first study demonstrating week-long drug delivery after one microneedle application, which would increase patient compliance and allow delivery of therapies for chronic diseases.Keywords
This publication has 18 references indexed in Scilit:
- Influence of skin type, race, sex, and anatomic location on epidermal barrier functionClinics in Dermatology, 2012
- Kinetics of skin resealing after insertion of microneedles in human subjectsJournal of Controlled Release, 2011
- Diclofenac Enables Prolonged Delivery of Naltrexone Through Microneedle-Treated SkinPharmaceutical Research, 2011
- Transdermal Delivery of Naltrexol and Skin Permeability Lifetime after Microneedle Treatment in Hairless Guinea PigsJournal of Pharmaceutical Sciences, 2010
- Micro-scale devices for transdermal drug deliveryInternational Journal of Pharmaceutics, 2008
- Transdermal drug deliveryNature Biotechnology, 2008
- Microneedles permit transdermal delivery of a skin-impermeant medication to humansProceedings of the National Academy of Sciences, 2008
- Differential suppression of dendritic cell cytokine production by anti-inflammatory drugsBritish Journal of Dermatology, 2007
- Development and validation of a liquid chromatography–mass spectrometry method for the quantitation of naltrexone and 6β-naltrexol in guinea pig plasmaJournal of Chromatography B, 2004
- Current status and future potential of transdermal drug deliveryNature Reviews Drug Discovery, 2004